U.S., Oct. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07216313) titled 'A Drug-Drug Interaction Study of Denifanstat and Resmetirom in Healthy Adult Participants' on Oct. 08.
Brief Summary: This is an open-label, 2-cohort study to evaluate the mutual DDI potential between denifanstat and resmetirom in healthy adult participants.
Study Start Date: Sept. 30
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: Denifanstat
Once daily
DRUG: Resmetirom
Once daily
Recruitment Status: RECRUITING
Sponsor: Sagimet Biosciences Inc.
Published by HT Digital Content Services with permission from Health Daily Digest....